Chesley Taft & Associates’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.23M Buy
26,392
+2,202
+9% +$178K 0.09% 156
2026
Q1
$1.71M Sell
24,190
-929
-4% -$69.6K 0.07% 171
2025
Q4
$1.98M Buy
25,119
+3,471
+16% +$275K 0.08% 164
2025
Q3
$1.78M Buy
21,648
+1,421
+7% +$112K 0.08% 164
2025
Q2
$1.63M Buy
20,227
+1,199
+6% +$92.5K 0.07% 165
2025
Q1
$1.53M Buy
19,028
+1,180
+7% +$98.1K 0.07% 167
2024
Q4
$1.46M Buy
17,848
+218
+1% +$18.1K 0.07% 169
2024
Q3
$1.45M Buy
17,630
+563
+3% +$42.1K 0.07% 165
2024
Q2
$1.2M Sell
17,067
-112
-0.7% -$8K 0.06% 174
2024
Q1
$1.27M Buy
17,179
+585
+4% +$40.8K 0.07% 169
2023
Q4
$1.1M Buy
16,594
+804
+5% +$50.3K 0.06% 177
2023
Q3
$993K Buy
15,790
+255
+2% +$15.9K 0.06% 177
2023
Q2
$878K Hold
15,535
0.05% 183
2023
Q1
$900K Hold
15,535
0.06% 182
2022
Q4
$1.12M Hold
15,535
0.08% 157
2022
Q3
$944K Hold
15,535
0.07% 166
2022
Q2
$975K Sell
15,535
-30
-0.2% -$1.99K 0.07% 170
2022
Q1
$1.09M Buy
15,565
+450
+3% +$30.4K 0.06% 175
2021
Q4
$945K Hold
15,115
0.05% 189
2021
Q3
$933K Hold
15,115
0.05% 182
2021
Q2
$905K Buy
15,115
+100
+0.7% +$6.34K 0.05% 185
2021
Q1
$925K Hold
15,015
0.06% 177
2020
Q4
$705K Hold
15,015
0.05% 187
2020
Q3
$558K Sell
15,015
-100
-0.7% -$3.8K 0.04% 194
2020
Q2
$552K Sell
15,115
-200
-1% -$6.96K 0.04% 189
2020
Q1
$468K Hold
15,315
0.04% 189
2019
Q4
$781K Sell
15,315
-500
-3% -$24.1K 0.06% 180
2019
Q3
$746K Buy
15,815
+30
+0.2% +$1.43K 0.06% 179
2019
Q2
$784K Hold
15,785
0.06% 171
2019
Q1
$672K Sell
15,785
-550
-3% -$24.3K 0.06% 184
2018
Q4
$671K Sell
16,335
-1,750
-10% -$75.1K 0.06% 179
2018
Q3
$845K Hold
18,085
0.07% 181
2018
Q2
$789K Hold
18,085
0.07% 184
2018
Q1
$830K Sell
18,085
-18,577
-51% -$901K 0.07% 178
2017
Q4
$1.85M Sell
36,662
-198
-0.5% -$10.4K 0.16% 126
2017
Q3
$1.92M Sell
36,860
-6,589
-15% -$321K 0.17% 125
2017
Q2
$2.13M Buy
43,449
+611
+1% +$28.3K 0.19% 110
2017
Q1
$2.02M Buy
42,838
+191
+0.4% +$9.11K 0.19% 110
2016
Q4
$2.05M Sell
42,647
-157
-0.4% -$7.2K 0.2% 101
2016
Q3
$1.7M Sell
42,804
-44,235
-51% -$1.66M 0.17% 114
2016
Q2
$3.09M Buy
87,039
+2,559
+3% +$99.8K 0.32% 83
2016
Q1
$3.31M Sell
84,480
-156,844
-65% -$5.86M 0.35% 81
2015
Q4
$10.4M Sell
241,324
-44,317
-16% -$1.95M 1.09% 29
2015
Q3
$12M Buy
285,641
+3,329
+1% +$156K 1.31% 23
2015
Q2
$14.1M Buy
282,312
+11,865
+4% +$562K 1.44% 21
2015
Q1
$12.2M Buy
270,447
+7,349
+3% +$330K 1.25% 23
2014
Q4
$12.7M Buy
263,098
+10,957
+4% +$521K 1.28% 23
2014
Q3
$12.1M Buy
252,141
+62,743
+33% +$3.05M 1.26% 23
2014
Q2
$9.38M Buy
189,398
+120,984
+177% +$5.66M 0.97% 38
2014
Q1
$3.22M Buy
68,414
+785
+1% +$36.1K 0.34% 83
2013
Q4
$3.25M Buy
67,629
+27
+0% +$1.21K 0.32% 87
2013
Q3
$2.83M Buy
67,602
+449
+0.7% +$19.3K 0.31% 90
2013
Q2
$2.74M Buy
+67,153
New +$2.47M 0.32% 87

Other funds holding MET

Chesley Taft & Associates's MET Position: Q2 2026 in Review

Chesley Taft & Associates increased its MetLife (MET) stake by 9.1% in Q2 2026, buying an estimated $178K and bringing the position to 26,392 shares worth $2.23M. The position accounts for 0.09% of the portfolio, ranked #156.

Chesley Taft & Associates first reported a position in MET in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.1M in Q2 2015. 253 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Chesley Taft & Associates held 26,392 shares of MetLife worth $2.23M as of Q2 2026.
  • Chesley Taft & Associates bought 2,202 MetLife shares in Q2 2026, an estimated $178K.
  • MetLife made up 0.09% of Chesley Taft & Associates's portfolio in Q2 2026, its #156 holding.
  • Chesley Taft & Associates first reported a position in MetLife in Q2 2013 and has held it in 53 quarters since.
  • Chesley Taft & Associates's MetLife position peaked at $14.1M in Q2 2015.
  • 253 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Chesley Taft & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.